Fluoroquinolone utilization among inpatients in a teaching hospital in Western Nepal

Journal of the Pakistan Medical Association

Volumn 57, Issue 2, 2007, Pages 78-82

  Shankar, P Ravi ^a   Upadhyay, Dinesh K ^a   Mishra, Pranaya ^a   Subish, P ^a   Dubey, Arun K ^a   Saha, Archana C ^a  

^a MANIPAL COLLEGE OF MEDICAL SCIENCES   (Nepal)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; CEFTRIAXONE; CIPROFLOXACIN; CLOXACILLIN; GENTAMICIN; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RANITIDINE; QUINOLONE DERIVATIVE;

ACUTE GASTROENTERITIS; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; CLINICAL PRACTICE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG COST; DRUG INFORMATION; DRUG USE; ESCHERICHIA COLI; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACY; PRESCRIPTION; PSEUDOMONAS AERUGINOSA; SENSITIVITY ANALYSIS; STAPHYLOCOCCUS AUREUS; TEACHING HOSPITAL; TREATMENT DURATION; TREATMENT INDICATION; URINARY TRACT INFECTION; ACUTE DISEASE; ADULT; ANTIBIOTIC PROPHYLAXIS; COST; ECONOMICS; GASTROENTERITIS; LENGTH OF STAY; MIDDLE AGED; NEPAL; STATISTICS;

ACUTE DISEASE; ADULT; ANTIBIOTIC PROPHYLAXIS; COSTS AND COST ANALYSIS; FEMALE; FLUOROQUINOLONES; GASTROENTERITIS; HOSPITALS, TEACHING; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NEPAL; PHYSICIAN'S PRACTICE PATTERNS; URINARY TRACT INFECTIONS;

EID: 34047265124     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Srishyla MV, Krishnamurthy M, Naga Rani MA, Mary Clare Sr, Andrade C, Venkataraman BV. Prescription audit in an Indian hospital setting using the DDD (defined daily dose) concept. Indian J Pharmacol 1994;26:23-8.
2. Rogues AM, Placet-Thomazeau B, Parneix P, Vincent I, Ploy MC, Marty N, et al. Use of antibiotics in hospitals in south-western France. J Hosp Infect 2004; 58:187-92.
3. Lew DP, Garbino J, Gerber AU, Sudre P. Use of antimicrobials in Swiss hospitals. Swiss Committee of Anti-infective agents. Drugs 1996; 52:88-91.
4. Rehana HS, Nagarani MA. A study on the drug prescribing patter and use of antimicrobial agents at a tertiary care teaching hospital in eastern Nepal. Indian J Pharmacol 1998; 30:175-80.
5. WHO Policy perspectives on Medicines, April 2005. Containing antimicrobial resistance. http://www.who.int/medicines/library/general/ PPMedicines/ppm_10_en.pdf. Accessed on July 19th, 2005.
6. Department of Health Services Annual report 2058/59 BS. (2001/2002). Department of Health Services, Ministry of Health, Kathmandu, Nepal.
7. Ghosh R, Neogi JN, Srivastava BS, Sen P. Prescribing trends in a teaching hospital in Nepal. J Nep Med Assoc 2003; 42:346-9.
8. Shankar RP, Partha P, Shenoy NK, Easow JM, Brahmadathan KN. Prescribing patterns of antibiotics and sensitivity patterns of common microorganisms in the Internal Medicine ward of a teaching hospital in Western Nepal: a prospective study. Ann Clin Microbiol Antimicrob. 2003; 2:7.
9. Gaynes R. The impact of antimicrobial use on the emergence of antimicrobial resistant bacteria in hospitals. Infect Dis Clin North Am 1997; 11:757-65.
10. Carmeli Y, Troillet N, Eliopoulos GM, Samore MH. Emergence of antibiotic resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother. 1999; 43:1379-82.
11. Linder JA, Huang ES, Steinman MA, Gonzales R, Stafford RS. Fluoroquinolone prescribing in the United States: 1995 to 2002. Am J Med 2005; 118:259-68.
12. Lutters M, Herrmann F, Dayer P, Vogt N. Antibiotic utilization in a university geriatric hospital and drug formularies. Schweiz Med Wochenschr 1998; 128:268-71.
13. Carrie AG, Metge CJ, Zhanel GG. Antibiotic use in a Canadian province, 1995-1998. Ann Pharmacother 2000; 34:459-64.
14. Urbanek K, Kolar M, Strojil J, Koukalova D, Cekanova L, Hejnar P. Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatients. Pharmacoepidemiol Drug Saf 2005; 14:741-5.
15. Zervos MJ, Hershberger E, Nicolau DP, Ritchie DJ, Blackner LK, Coyle EA, et al. Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. Clin Infect Dis 2003; 37:1643-8.
16. WHO Collaborating Centre for Drug Statistics Methodology. ATC index with DDDs 2002. Oslo 2002.
17. Xavier D. Pharmacoepidemiology and drug utilization studies. In: Continuing medical education Workshop in Pharmacology 9th-12th February 1999. Department of Pharmacology, St. John's Medical College, Bangalore, India.
18. Palikhe N. Prescribing pattern of antibiotics in paediatric hospital of Kathmandu valley. Kadimandu Univ Med J 2004; 2:6-12.
19. Pariente-Khayat A, Vauzelle-Kervroedan F, d'Athis P, Breart G, Gendrel D, Aujard Y, et al. Retrospective survey of fluoroquinolone use in children. Arch Pediatr 1998; 5:484-8.
20. Green S, Tillotson G. Use of ciprofloxacin in developing countries. Pediatr Infect Dis J 1997; 16:150-9..
21. Das BP, Sethi A, Rauniar GP. Antimicrobial utilization pattern in a teaching district hospital of Nepal. J Nep Med Assoc 2004; 43:119-24.
22. Dydek GJ, Souney PF, Matthews SJ. DUE of ciprofloxacin in the treatment of urinary tract infections in hospitalized patients. Hosp Formul 1992;27:185-91.
23. Kern WV, Steib-Bauert M, de With K, Reuter S, Bertz H, Frank U, et al. Fluoroquinolone consumption and resistance in haematology-oncology patients: an ecological analysis in two university hospitals 1999-2002. J Antimicrob Chemother 2005; 55:57-60.
24. Weller TM. The successful introduction of a programme to reduce the use of iv ciprofloxacin in hospital. J Antimicrob Chemother 2002;49:827-30.